Healthcare Special Opportunities Fund
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Healthcare Special Opportunities Fund generated cash of $1,110,731, which is less than the previous year. Cash used in financing activities reached the amount of -$3,886,848 last year. Net change in cash is therefore -$2,758,485.
Cash Flow
| 2015 | -68.79M | 0 | 69.41M |
|---|---|---|---|
| 2016 | 7.21M | 0 | -163.32K |
| 2017 | 29.57M | 0 | -32.23M |
| 2018 | 11.50M | 0 | -12.51M |
| 2019 | 3.34M | 0 | -5.03M |
| 2020 | 1.84M | 0 | -2.19M |
| 2021 | 3.71M | 0 | -975.03K |
| 2022 | 7.86M | 0 | -8.48M |
| 2023 | 1.11M | 0 | -3.88M |
MDS-UN.TO Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.10M | 3.33M | 544.83K | 689.96K | 2.35M | 3.37M | 7.53M | 792.53K | 0 |
Operating activities | |||||||||
Net income | 437.26K | -5.36M | 1.24M | 1.83M | 5.53M | 4.85M | 7.78M | 2.97M | -4.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 22.33K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 1.11M | 7.86M | 3.71M | 1.84M | 3.34M | 11.50M | 29.57M | 7.21M | -68.79M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72.28M |
Payments for dividends | -378.20K | -573.23K | -709.48K | -1.17M | -886.81K | 0 | -393.75K | 0 | 0 |
Repurchases of common stock | -3.50M | -7.91M | -265.54K | -1.01M | -4.14M | -11.88M | -31.83M | -161.38K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -3.88M | -8.48M | -975.03K | -2.19M | -5.03M | -12.51M | -32.23M | -163.32K | 69.41M |
Net Change In Cash | -2.75M | -227.06K | 2.78M | -145.13K | -1.66M | -1.01M | -4.16M | 6.74M | 792.53K |
Cash at end of period | 347.37K | 3.10M | 3.33M | 544.83K | 689.96K | 2.35M | 3.37M | 7.53M | 792.53K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |